← All patents

US20170176440A1

Methods and compositions for evaluating breast cancer patients

University of Texas System

Abstract

Embodiments are directed to methods of evaluating the prognosis of a breast cancer patient by assessing the level of phosphorylation tyrosine 36 of estrogen receptor beta (ERB). Certain embodiments are directed to methods for evaluating the prognosis of a cancer patient comprising contacting a …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Rong Li
Priority date
March 27, 2014
Filing date
March 26, 2015
Publication date
June 22, 2017
Language
en
Metadata fetched
August 29, 2026 00:25